Abstract

Basics of Compounding: Basics of Compounding with Organic Salts

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 2010 - Sterile Compounding

Page(s): 322-326

Download in electronic PDF format for $75
  • Basics of Compounding: Basics of Compounding with Organic Salts Page 1
  • Basics of Compounding: Basics of Compounding with Organic Salts Page 2
  • Basics of Compounding: Basics of Compounding with Organic Salts Page 3
  • Basics of Compounding: Basics of Compounding with Organic Salts Page 4
  • Basics of Compounding: Basics of Compounding with Organic Salts Page 5

Abstract

The purity and form of all ingredients used in compounding, especially of active pharmaceutical ingredients, must be known and considered during formulation. When a prescription is received, it is the responsibility of the pharmacist, and should be routine procedure, to correctly determine whether or not the salt or base/acid form of a drug is to be used as the basis for the dose. This is important information because the bulk substance, or active pharmaceutical ingredient, in a salt form is not 100% active drug. The purpose of the salt form is usually to enhance the solubility of the drug, but it may also enhance and change other attributes of the drug that make it easier to handle and manipulate for producing dosage forms. Resources for the purpose of determining this information include the United States Pharmacopeia, product package insert, and a call to the manufacturer or physician as appropriate. This article discusses compounding with salts and the factors that may affect a final compounded preparatio

Related Keywords

  • organic salts
  • active drug
  • drug solubility
  • bulk drugs
  • United States Pharmacopeia
  • USP articldes
  • dosage forms

Related Categories

  • SUPPORT
  • QUALITY CONTROL
  • UNITED STATES PHARMACOPEIA CONVENTIONS
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2010
Pg. 322-326
Basics of Compounding: Basics of Compounding with Organic Salts
Author(s): Allen Loyd V Jr
Jan/Feb 2017
Pg. 47-56
Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms
Author(s): Akers Michael J
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Jan/Feb 2020
Pg. 30-36
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Author(s): Dillon L R
Mar/Apr 2020
Pg. 92
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1
Author(s): Allen Loyd V Jr
Jul/Aug 2015
Pg. 303-305
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Author(s): Miller David G
May/Jun 2020
Pg. 180
PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2
Author(s): Allen Loyd V Jr
Sep/Oct 2017
Pg. 356
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Author(s): Allen Loyd V Jr
May/Jun 2011
Pg. 234-238
Basics of Compounding: Basics of Compounding with Complex Organic Molecules
Author(s): Allen Loyd V Jr
Mar/Apr 2011
Pg. 146-153
Basics of Compounding: Basics of Compounding with Inorganic Salts
Author(s): Allen Loyd V Jr
Sep/Oct 2018
Pg. 401-404
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Author(s): Martin Matt
May/Jun 2016
Pg. 202-206
Does Your Drug Expertise Include Clinical Pharmaceutics?
Author(s): Newton David W
Mar/Apr 2022
Pg. 118-126
Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins
Author(s): Allen Loyd V Jr
Jul/Aug 2016
Pg. 351
View Sample
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Author(s): Allen Loyd V Jr
Jan/Feb 2009
Pg. 56-62
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 11: Hazardous Drugs
Author(s): Allen Loyd V Jr, Okeke Claudia C
Jul/Aug 2011
Pg. 328-331
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 1
Author(s): Allen Loyd V Jr
Jan/Feb 2012
Pg. 64-68
Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding–Nonsterile Preparations, Part 4
Author(s): Allen Loyd V Jr
Nov/Dec 2006
Pg. 446-448
Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 491-496
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations
Author(s): Allen Loyd V Jr
Mar/Apr 2012
Pg. 146-150
Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 1
Author(s): Allen Loyd V Jr